Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-08

Clinical Trial Update: Impact of Estrogen + Estradiol Receptor Alpha Modulator Therapy on Oxidative Stress in Post-menopausal Women With and Without Sleep Apnea [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial exploring the impact of Estrogen + Estradiol Receptor Alpha Modulator therapy on oxidative stress in post-menopausal women with and wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Estrogen + Estradiol Receptor Alpha Modulator therapy

Snippet

Sponsor: Laval University | Conditions: Sleep Apnea, Post Menopausal | Phase 3 | Status: UNKNOWN